Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway.
Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Dev Med Child Neurol. 2021 May;63(5):537-544. doi: 10.1111/dmcn.14797. Epub 2021 Jan 3.
To determine the prevalence of long-term mechanical insufflation-exsufflation (MI-E) and concomitant mechanical ventilation in children with neurological conditions, with reported reasons behind the initiation of treatment.
This was a population-based, cross-sectional study using Norwegian national registries and a questionnaire.
In total, 114 of 19 264 children with a neurological condition had an MI-E device. Seventy-three of 103 eligible children (31 females, 42 males), median (min-max) age of 10 years 1 month (1y 5mo-17y 10mo), reported their MI-E treatment initiation. Overall, 76% reported airway clearance as the main reason to start long-term MI-E. A prophylactic use was mainly reported by children with neuromuscular disorders (NMDs). Prevalence and age at initiation differed by diagnosis. In spinal muscular atrophy and muscular dystrophies, MI-E use was reported in 34% and 7% of children, of whom 83% and 57% respectively received ventilator support. One-third of the MI-E users were children with central nervous system (CNS) conditions, such as cerebral palsy and degenerative disorders, and ventilator support was provided in 31%. The overall use of concomitant ventilatory support among the long-term MI-E users was 56%.
The prevalence of MI-E in a neuropaediatric population was 6 per 1000, with two-thirds having NMDs and one-third having conditions of the CNS. The decision to initiate MI-E in children with neurological conditions relies on clinical judgment.
The prevalence and age at initiation of mechanical insufflation/exsufflation (MI-E) differed between diagnoses. MI-E was most commonly used in spinal muscular atrophy, where it generally coincided with ventilatory support. One-third of MI-E devices were given to children with central nervous system conditions, and one-third also received ventilatory support.
确定患有神经疾病的儿童长期机械通气-呼气(MI-E)和同时进行机械通气的流行情况,并报告治疗开始的原因。
这是一项基于人群的横断面研究,使用了挪威国家登记处和问卷调查。
在 19264 名患有神经疾病的儿童中,共有 114 名儿童使用了 MI-E 设备。在 103 名符合条件的儿童中,有 73 名(31 名女性,42 名男性)报告了他们的 MI-E 治疗开始,中位(最小-最大)年龄为 10 岁 1 个月(1y 5mo-17y 10mo)。总体而言,76%的人报告气道清除是开始长期 MI-E 的主要原因。预防性使用主要由神经肌肉疾病(NMDs)患儿报告。脊髓性肌萎缩症和肌肉营养不良症患儿的 MI-E 使用分别报告为 34%和 7%,其中分别有 83%和 57%的患儿接受了呼吸机支持。三分之一的 MI-E 使用者是患有中枢神经系统(CNS)疾病的儿童,如脑瘫和退行性疾病,并提供了 31%的呼吸机支持。长期使用 MI-E 的患者中有三分之一的人患有 CNS 疾病,如脑瘫和退行性疾病,并且有 31%的人接受了呼吸机支持。长期 MI-E 使用者同时使用呼吸机支持的总体比例为 56%。
在神经儿科人群中,MI-E 的患病率为每 1000 人 6 例,其中三分之二患有 NMDs,三分之一患有 CNS 疾病。在患有神经疾病的儿童中开始使用 MI-E 的决定依赖于临床判断。
不同诊断的 MI-E 患病率和起始年龄不同。MI-E 最常用于脊髓性肌萎缩症,通常与呼吸机支持同时使用。三分之一的 MI-E 设备用于患有中枢神经系统疾病的儿童,其中三分之一也接受呼吸机支持。